Suicides during 7 years among a catchment area cohort of patients with psychoses

Nordic Journal of Psychiatry

Volumn 66, Issue 1, 2012, Pages 8-13

  Lindström, Eva ^a   Eriksson, Lars ^a   Levander, Sten ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b MALMÖ UNIVERSITY   (Sweden)

Author keywords

Antipsychotic drugs; Compliance; Psychosis; Schizophrenia; Suicide

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT;

ARTICLE; AUTOPSY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMAN; PATIENT COMPLIANCE; POPULATION RESEARCH; PSYCHOLOGICAL ASPECT; PSYCHOSIS; SOCIAL INTERACTION; SUICIDE; SUICIDE ATTEMPT;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SOCIAL ISOLATION; SUICIDE; YOUNG ADULT;

EID: 84855713859     PISSN: 08039488     EISSN: 15024725     Source Type: Journal    
DOI: 10.3109/08039488.2011.577186     Document Type: Article

References (48)

1. Hawton K, Zahl D, Weatherall R. Suicide following deliberate self-harm: Long-term follow-up of patients who presented to a general hospital. Br J Psychiatry 2003;182:537-42. (Pubitemid 36649201)
2. Palmer BA, Pankratz VS, Bostwick JM. The lifetime risk of suicide in schizophrenia: A reexamination. Arch Gen Psychiatry 2005;62:247-53. (Pubitemid 40990969)
3. Limosin F, Loze JY, Philippe A, Casadebaig F, Rouillon F. Ten-year prospective follow-up study of the mortality by suicide in schizophrenic patients. Schizophr Res 2007;94:23-8. (Pubitemid 47031602)
4. Siris SG. Suicide and schizophrenia. J Psychopharmacol 2001;15:127-35. (Pubitemid 32619590)
5. Bushe CJ, Taylor M, Haukka J. Mortality in schizophrenia: A measurable clinical endpoint. J Psychopharmacol 2010;24 Suppl:17-25.
6. Ö sby U, Correia N, Brandt L, Ekbom A, Sparen P. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res 2000;45:21-8.
7. Allebeck P, Varla A, Kristjansson E, Wistedt B. Risk factors for suicide among patients with schizophrenia. Acta Psychiatr Scand 1987;76:414-19.
8. Gut-Fayand A, Dervaux A, Olie JP, Loo JP, Poirier MF, Krebs MO. Substance abuse and suicidality in schizophrenia: A common risk factor linked to impulsivity. Psychiatry Res 2001;10:65-72. (Pubitemid 32463926)
9. Busch KA, Fawsett J, Jacobs DG. Clinical correlates of inpatient suicide. J Clin Psychiatry 2003;64:14-19. (Pubitemid 36182224)
10. Pinikahana J, Happell B, Keks NA. Suicide and schizophrenia: A review of literature for the decade (1990-1999) and implications for mental health nursing. Issues Ment Health Nurs 2003;24:27-43. (Pubitemid 37431196)
11. Lambert TJ, Velakoulis D, Pantelis C. Medical comorbidity in schizophrenia. Med J Aust 2003;5 Suppl:67-70.
12. Hennekens CH. Increased global burden of cardiovascular disease in general population and in patients with schizophrenia. J Clin Psychiatry 2007;68 Suppl 4:4-7. (Pubitemid 46762117)
13. Bertelsen M, Jeppesen P, Petersen L, Thorup A, Ø hlenschlaeger J, le Quach P, et al. Suicidal behaviour and mortality in fi rst-episode psychosis: The OPUS trial. Br J Psychiatry Suppl 2007;51:140-6.
14. Pompili M, Amador XF, Girardi P, Harkavy-Friedman JM, Harrow M, Kaplan K, et al. Suicide risk in schizophrenia: Learning from the past to change the future. Annals Gen Psychiatry 2007;16:6-10.
15. Tiihonen J, Lönnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, et al. 11-year follow-up of mortality in patients with schizophrenia: A population-based cohort study (FIN11 study). Lancet 2009;374:620-7.
16. Hor K, Taylor M. Suicide and schizophrenia: A systematic review of rates and risk factors. J Psychopharmacol 2010;24 Suppl:81-90.
17. Altamura AC, Bassetti R, Bignotti S, Pioli R, Mundo E. Clinical variables related to suicide attempts in schizophrenic patients: A retrospective study. Schizophr Res 2003;60:47-55. (Pubitemid 36015787)
18. Kim CH, Jayathilake K, Meltzer HY. Hopelessness, neurocognitive function, and insight in schizophrenia: Relation to suicidal behaviour. Schizophr Res 2003;60:71-80.
19. C ooper J, Appleby L, Amos T. Life events preceding suicide by young people. Soc Psychiatry Epidemiol 2002;37:271-5. (Pubitemid 36067963)
20. Baca-Garcia E, Perez-Rodrigues MM, Diaz Sastre C, Saiz-Ruiz J, de Leon J. Suicidal behaviour in schizophrenia and depression: A comparison. Schizophr Res 2005;75:77-81. (Pubitemid 40487976)
21. Alphs L, Anand R, Zahur Islam M, Meltzer HY, Kane JM, Krishnan R, et al. The International Suicide Prevention Trial (InterSePT): Rationale and design of a trial comparing the relative ability of clozapine and olanzapine to reduce suicidal behavior in schizophrenia and schizoaffective patients. Schizophr Bull 2004;30:577-86. (Pubitemid 39625698)
22. Modestin J, Dal Pian D, Agarwalla P. Clozapine diminishes suicidal behaviour: A retrospective evaluation of clinical records. J Clin Psychiatry 2005;66:534-38. (Pubitemid 40593584)
23. Ginsberg DL, Schooler NR, Buckley PF, Harvey PD, Weiden PJ. Optimizing treatment of schizophrenia. Enhancing affective/cognitive and depressive functions. CNS Spectr 2005;10:1-13.
24. Kasckow J, Felmet K, Zisook S. Managing suicide risk in patients with schizophrenia. CNS Drugs 2011;25:129-43.
25. Glick ID, Zaninelli R, Hsu C, Young FK, Weiss L, Gunay I, Kumar V. Patterns of concomitamt psychotropic medication use during a 2-year study comparing clozapine and olanzapine for the prevention of suicidal behaviour. J Clin Psychiatry 2004;65:679-85.
26. Lindström E, Eberhard J, Levander S. Five years follow-up during antipsychotic treatment; Effi cacy, safety and social outcome. Acta Psychiatr Scand Suppl 1997;435:5-16.
27. Ponizovsky AM, Grinshpoon A, Levav I, Ritsner MS. Life satisfaction and suicid attempts among persons with schizophrenia. Compr Psychiatry 2003;44:442-7. (Pubitemid 37420710)
28. Tong Y, Phillips MR. Cohort-specifi c risk of suicide for different mental disorders in China. Br J Psychiatry 2010;196:467-73.
29. Salokangas RK, Honkonen T, Stengard E, Koivisto AM. Mortality in schronic schizophrenia during decreasing number of psychiatric beds in Finland. Schizophr Res 2002;54:265-5.
30. Heila H, Haukka J, Suvisaari J, Lonnqvist J. Mortality among patients with schizophrenia and reduced psychiatric hospital care. Psychol Med 2005;35:725-32. (Pubitemid 40716436)
31. Harkavy-Friedman JM, Kimhy D, Nelson EA, Venarde DF, Malaspina D, Mann JJ. Suicide attempts in schizophrenia: The role of command auditory hallucinations for suicide. J Clin Psychiatry 2003;64:871-4. (Pubitemid 37022751)
32. Grunebaum MF, Oquendo MA, Harkavy-Friedman JM, Ellis SP, Li S, Haas GL, et al. Delusions and suicidality. Am J Psychiatry 2001;158:742-7. (Pubitemid 32429842)
33. Whitehead C, Moss S, Cardno A, Lewis G. Antidepressants for the treatment of depression in people with schizophrenia: A systematic review. Psychol Med 2003;33:589-99. (Pubitemid 36626041)
34. Dervaux A, Laqueille X, Bourdel MC, Leborgne MH, Olie JP, Loo H, et al. Cannabis and schizophrenia: Demographic and clinical correlates. Encephale 2003;29:11-17. (Pubitemid 36361972)
35. Akerele EO, Levin FR. Substance abuse among patients with schizophrenia. J Psychiatr Pract 2002;8:70-80.
36. Eberhard J, Riley F, Levander S. Premorbid IQ and schizophrenia- Increasing cognitive reduction by episodes. Eur Arch Psy Clin Neurosci 2003;253:84-8. (Pubitemid 37205482)
37. Qin P, Nordentoft M. Suicide risk in relation to psychiatric hospitalization: Evidence based on longitudinal registers. Arch Gen Psychiatry 2005;62:427-32. (Pubitemid 40471692)
38. Steblaj A, Tavcar R, Dernovsek MZ. Predictors of suicide in psychiatric hospitals. Acta Psychiatr Scand 1999;100: 383-8.
39. Nyman AK, Jonsson H. Pattern of self-destructive behaviour in schizophrenia. Acta Psychiatr Scand 1986;73:252-62.
40. Heilä H, Isometsä ET, Henriksson MM, Heikkinen ME, Marttunen MJ, Lönnqvist JK. Suicide and schizophrenia: A nationwide psychological autopsy study on age- and sex-specifi c clinical characteristics of 92 suicide victims with schizophrenia. Am J Psychiatry 1997;154: 1235-42.
41. Proulx F, Lesage AD, Grunberg F. One hundred in-patient suicides. Br J Psychiatry 1997;171:247-50. (Pubitemid 27400299)
42. Emmerson B, Cantor C. Train suicides in Brisbane, Australia, 1980-1986. Crisis 1993;14:90-4.
43. Lindström E, Bingefors K. Patient compliance with drug therapy in schizophrenia - Economic and clinical issues. Pharmacoeconomics 2000;18:105-24.
44. Rettenbacher MA, Hofer A, Eder U, Hummer M, Kemmler G, Weiss EM, Fleischhacker WW. Compliance in schizophrenia: Psychopathology, side effects, and patients ' attitudes toward the illness and medication. J Clin Psychiatry 2004;65:1211-8.
45. Herings RM, Erkens JA .Increased suicide attempt rate among patients interrupting use of atypical antipsychotics. Pharmacoepidemiol Drug Safe 2003;12:423-4. (Pubitemid 36903380)
46. Reutfors J, Brandt L, Jönsson EG, Ekbom A, Sparé n P, Ö sby U. Risk factors for suicide in schizophrenia: Findings from a Swedish population-based case-control study. Schizophr Research 2009;108:231-7.
47. Pompili M, Ruberto A, Kotzalidis GD, Girardi P, Tatarelli R . Awareness of illness and suicide in schziophrenia: An overview. Bull Menninger Clin. 2004;68:297-318.
48. Restifo K, Harkavy-Friedman JM, Shrout PE. Suicidal behavior in schizophrenia: A test of the demoralization hypothesis. J Nerv Ment Dis 2009;97:147-53.